Beckman coulter introduces cutting-edge research use only assays for neurodegenerative disease research

New, fully automated, high-throughput ruo assays offered on beckman coulter immunoassay analyzers brea, calif. , jan. 15, 2025 /prnewswire/ -- beckman coulter diagnostics, a global leader in advanced diagnostics, today announced availability of new research use only (ruo) blood-based biomarker immunoassays designed to advance neurodegenerative disease research.
DHR Ratings Summary
DHR Quant Ranking